Yes, exactly the point. Folks who want existing cannabis cultivars to remain in the public domain support the Open Cannabis Project, and those who want to protect proprietary strains they've developed don't (or the don't for THEIR strains.) What do Skunkman, Reeferman Chimera or BioTech Institute LLC have to do with Phylos? Proprietary breeders are exactly why we need the OCP and Phylos' Galaxy project.
Here what Patent Docs, no "weed site" for sure, has to say about the BioTech patent apps in particular:
....commentators have speculated that Biotech Institute's patents may cover anywhere from 50-70% of all Cannabis plants that are currently on the market, which could pose a serious threat to many Cannabis growers. Unlike plant patents, which are narrow and cover a particular, well-defined new plant variety, utility patents directed to plants have the potential to claim a much broader range of varieties.
Further, the potential sweeping scope of these patents, specifically, highlights a couple of issues with prosecuting and challenging patents on Cannabis plants, generally. For example, there would seem to be a lack of prior art available showing the particular chemotypes of strains that are currently in use. Without this information, Examiners are unable to accurately determine whether a Cannabis plant with a particular chemotype is novel and nonobvious. Moreover, the lack of publications or information on the Cannabis varieties currently available to the public may pose similar challenges for third parties seeking to initiate certain post-grant review proceedings before the USPTO of patents covering Cannabis plants. Indeed, perhaps unsurprisingly, none of the patents in this family have yet been subjected to an IPR proceeding.
Regardless of this lack of post-grant challenges or proceedings for the Biotech cannabis patents, however, these concerns have become apparent by other market reactions in the industry. For example, in direct response to these issues and Biotech Institute's patents in particular, groups such as the Open Cannabis Project ("OCP") are working to catalog and publish the chemotype data of cannabis strains that are currently in the public domain. OCP's mission, in part, is to prevent broad utility patent protection of Cannabis plants. Having such a database will help ensure that patents on Cannabis plants are properly limited in scope to cover novel and nonobvious varieties.